Preoperative Chemotherapy With Bevacizumab For Potentially Resectable Gastric Cancer With Liver Metastasis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The investigators assessed whether the addition of a preoperative regimen of Bevacizumab regimen to improves R0 resection rate and survival among patients with potentially resectable gastric cancer with liver metastasis.
Epistemonikos ID: 4de422b45ad5d9ac1e7910f47d8a2eaa0b7a348e
First added on: May 11, 2024